Matthijs van der Meulen

10PUBLICATIONS
24CO-AUTHORS
Solid tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCentral nervous systemTeacher education and professional development of educators
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 15, 2026
Primary central nervous system lymphoma-current standards and recent developments.

|Jun 09, 2025
The Effect of Concomitant Immunotherapy and Stereotactic Radiotherapy, and of Location on Survival in Patients With Brain Metastases From Melanoma.

Chiel B Nijboer, Djura Piersma, Angelique E J Sijben

|Feb 05, 2024
Differences in methylation profiles between long-term survivors and short-term survivors of IDH-wild-type glioblastoma.

Matthijs van der Meulen, Ronald C Ramos, Mathew R Voisin

|Dec 19, 2023
Primary central nervous system lymphoma.

Myrthe E de Koning, Jurrit J Hof, Casper Jansen

|Dec 01, 2023
Survival, neurocognitive function, and health-related quality of life outcomes after rituximab-methotrexate, BCNU, teniposide, and prednisolone for primary CNS lymphoma: Final results of the HOVON 105/ALLG NHL 24 study.

Jacoline E C Bromberg, Samar Issa, Bronno van der Holt

|Aug 29, 2023
The Value of Etoposide for Recurrent Glioma.

Matthijs van der Meulen, Manik Chahal, Warren P Mason

Pageof 2

Frequent Collaborators

3 joint publications

Jacoline E C Bromberg

3 joint publications

Jeanette K Doorduijn

2 joint publications

Samar Issa

1 joint publications

Sybren L N Maas